Acrivon Therapeutics, Inc. Common Stock

NASDAQ:ACRV

Biotechnology

Healthcare
$1.56 +3.16%

+$0.05 today

Market cap
$66.94M
Beta
1.91
P/E (TTM)
-0.8
EPS (TTM)
-$2.00
52W Low $1.15High $3.56

Volume 0.61M

Average 0.60M

ACRV Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How ACRV compares with its peers on the latest reported figures

ACRV Competitors Peer median
Net Margin for ACRV and competitors
Company Period LTM level YoY 3-year change
VXRTVaxart, Inc.LTM Mar 202614.5% +137.1 pp+100715.3 pp
TCRXTScan Therapeutics, Inc.LTM Mar 2026-1360.6% +1613.5 pp-767.6 pp
CBUSCibus, Inc.LTM Mar 2026-2366.3% +3418.5 pp+7266.3 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-36857.4% —-38572.9 pp
ACRVAcrivon Therapeutics, Inc. Common StockFY2025— ——
RLMDRelmada Therapeutics, Inc.FY2025— ——
IMUXImmunic, Inc.FY2025— ——
UNCYUnicycive Therapeutics, Inc.FY2025— ——
PMVPPMV Pharmaceuticals, Inc.FY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
Peer median (excluding ACRV) -1863.5%+1613.5 pp+3249.4 pp

Competitors are the stored peer set for ACRV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00536K1.01M1.36M
Gross Profit00(536K)(1.01M)(1.36M)
Gross Margin—————
Research & Development13.72M23.95M45.49M63.99M59.99M
Selling, General & Admin2.47M8.71M21.21M25.21M24.12M
Operating Expenses16.18M32.66M66.7M88.19M82.76M
Depreciation & Amortization37K364K536K1.01M1.36M
EBITDA(16.21M)(30.8M)(59.85M)(79.55M)(76.55M)
EBITDA Margin—————
Operating Income(16.18M)(32.66M)(67.24M)(89.2M)(84.11M)
Operating Margin—————
Interest Income007.04M9.2M6.48M
Interest Expense00000
Other Income / Expenses(59K)1.49M6.85M8.64M6.21M
Income Before Tax(16.24M)(31.17M)(60.39M)(80.56M)(77.91M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(16.24M)(31.17M)(60.39M)(80.56M)(77.91M)
Net Margin—————
EPS (Basic)(1.26)(1.42)(2.74)(2.10)(2.02)
EPS (Diluted)(1.26)(1.42)(2.74)(2.10)(2.02)
Weighted Avg Shares12.91M21.92M22.08M38.3M38.51M
Weighted Avg Shares (Diluted)12.91M21.92M22.08M38.3M38.51M

Acrivon Therapeutics, Inc. Common Stock

NASDAQ:ACRV

Intrinsic Alpha fair value

Locked

Current Price

$1.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.